JP2007520565A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520565A5 JP2007520565A5 JP2006552282A JP2006552282A JP2007520565A5 JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5 JP 2006552282 A JP2006552282 A JP 2006552282A JP 2006552282 A JP2006552282 A JP 2006552282A JP 2007520565 A5 JP2007520565 A5 JP 2007520565A5
- Authority
- JP
- Japan
- Prior art keywords
- animal
- human
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 0 CC(*(C)I)C=C(C(N(**)C1=C)=C)N(C)C1=I Chemical compound CC(*(C)I)C=C(C(N(**)C1=C)=C)N(C)C1=I 0.000 description 2
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54207304P | 2004-02-04 | 2004-02-04 | |
US62426204P | 2004-11-01 | 2004-11-01 | |
PCT/US2005/003636 WO2005077940A1 (en) | 2004-02-04 | 2005-02-04 | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007520565A JP2007520565A (ja) | 2007-07-26 |
JP2007520565A5 true JP2007520565A5 (he) | 2008-04-03 |
Family
ID=34864489
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006552282A Pending JP2007520565A (ja) | 2004-02-04 | 2005-02-04 | デヒドロフェニラヒスチン及びそれらの類似体、並びにデヒドロフェニラヒスチン及びそれらの類似体の合成 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1711487A1 (he) |
JP (1) | JP2007520565A (he) |
KR (1) | KR101228104B1 (he) |
AU (1) | AU2005212399B2 (he) |
BR (1) | BRPI0506655A (he) |
CA (1) | CA2553630A1 (he) |
IL (1) | IL176932A0 (he) |
NZ (1) | NZ548659A (he) |
WO (1) | WO2005077940A1 (he) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1529044E (pt) | 2002-08-02 | 2008-01-14 | Nereus Pharmaceuticals Inc | Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos |
US7919497B2 (en) | 2002-08-02 | 2011-04-05 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US7935704B2 (en) | 2003-08-01 | 2011-05-03 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
EP1926724A1 (en) * | 2005-09-21 | 2008-06-04 | Nereus Pharmaceuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
US8129527B2 (en) | 2006-11-03 | 2012-03-06 | Nereus Pharmacuticals, Inc. | Analogs of dehydrophenylahistins and their therapeutic use |
MX2016004441A (es) * | 2013-10-11 | 2016-10-28 | Beyondspring Inc | Tratamiento del cancer con una combinacion de plinabulina y taxano. |
EP3256130A4 (en) * | 2015-02-12 | 2018-08-01 | Beyondspring Pharmaceuticals, Inc. | Use of plinabulin in combination with immune checkpoint inhibitors |
KR102623404B1 (ko) | 2015-03-06 | 2024-01-11 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 뇌 종양 치료 방법 |
EP3265090A4 (en) | 2015-03-06 | 2018-08-01 | Beyondspring Pharmaceuticals Inc. | Method of treating cancer associated with a ras mutation |
EP3334726B1 (en) * | 2015-07-13 | 2022-03-16 | Beyondspring Pharmaceuticals, Inc. | Plinabulin compositions |
MY192703A (en) | 2016-02-08 | 2022-09-02 | Beyondspring Pharmaceuticals Inc | Compositions containing tucaresol or its analogs |
MX2018015100A (es) | 2016-06-06 | 2019-09-04 | Beyondspring Pharmaceuticals Inc | Composicion y metodo para reducir la neutropenia. |
CN114276332B (zh) | 2016-08-12 | 2023-08-18 | 深圳华大海洋科技有限公司 | 脱氢苯基阿夕斯丁类化合物的多晶型及其制备纯化方法和应用 |
JP2020503363A (ja) | 2017-01-06 | 2020-01-30 | ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド | チューブリン結合化合物およびその治療的使用 |
WO2018144764A1 (en) | 2017-02-01 | 2018-08-09 | Beyondspring Pharmaceuticals, Inc. | Method of reducing neutropenia |
EP3595653B1 (en) * | 2017-03-13 | 2023-03-08 | Beyondspring Pharmaceuticals, Inc. | Compositions of plinabulin and use thereof |
KR20200112881A (ko) | 2018-01-24 | 2020-10-05 | 비욘드스프링 파마수티컬스, 인코포레이티드. | 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법 |
CN108524442B (zh) * | 2018-06-05 | 2022-01-28 | 深圳海王医药科技研究院有限公司 | 一种抗肿瘤药物的注射剂及其制备方法 |
JP2018199726A (ja) * | 2018-09-26 | 2018-12-20 | ビヨンドスプリング インコーポレイテッド | プリナブリン及びタキサンの組合せがん治療 |
EP4412613A1 (en) * | 2021-10-07 | 2024-08-14 | Beyondspring Pharmaceuticals, Inc. | Methods for treating cancers and tumors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3318789C2 (de) * | 1983-05-24 | 1987-04-02 | Eduard Gerlach GmbH Chemische Fabrik, 4990 Lübbecke | Deodorant |
GB9402807D0 (en) * | 1994-02-14 | 1994-04-06 | Xenova Ltd | Pharmaceutical compounds |
US6069146A (en) * | 1998-03-25 | 2000-05-30 | The Regents Of The University Of California | Halimide, a cytotoxic marine natural product, and derivatives thereof |
US6358957B1 (en) * | 1998-11-12 | 2002-03-19 | Nereus Pharmaceuticals, Inc. | Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
WO2001053290A1 (fr) * | 2000-01-18 | 2001-07-26 | Nippon Steel Corporation | Inhibiteurs de la division cellulaire et procede de production de ces inhibiteurs |
US6635649B2 (en) * | 2000-05-09 | 2003-10-21 | Che-Ming Teng | Piperazinedione compounds |
PT1529044E (pt) * | 2002-08-02 | 2008-01-14 | Nereus Pharmaceuticals Inc | Desidrofenila-histinas e os seus análogos e a síntese de desidrofenila-histinas e os seus análogos |
-
2005
- 2005-02-04 AU AU2005212399A patent/AU2005212399B2/en not_active Ceased
- 2005-02-04 BR BRPI0506655-7A patent/BRPI0506655A/pt not_active IP Right Cessation
- 2005-02-04 CA CA002553630A patent/CA2553630A1/en not_active Abandoned
- 2005-02-04 KR KR1020067017883A patent/KR101228104B1/ko active IP Right Grant
- 2005-02-04 WO PCT/US2005/003636 patent/WO2005077940A1/en active Application Filing
- 2005-02-04 NZ NZ548659A patent/NZ548659A/en unknown
- 2005-02-04 JP JP2006552282A patent/JP2007520565A/ja active Pending
- 2005-02-04 EP EP05712910A patent/EP1711487A1/en not_active Withdrawn
-
2006
- 2006-07-18 IL IL176932A patent/IL176932A0/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007520565A5 (he) | ||
JP2006503588A5 (he) | ||
JP2006524283A5 (he) | ||
JP2009524695A5 (he) | ||
FR2881652B1 (fr) | Forme pharmaceutique orale microparticulaire anti-mesuage | |
FR2892937B1 (fr) | Forme pharmaceutique orale microparticulaire anti-mesusage | |
JP2003503454A5 (he) | ||
BRPI0714539A2 (pt) | "formas farmacêuticas" | |
JP2010525055A5 (he) | ||
JP2008519810A5 (he) | ||
JP2009504909A5 (he) | ||
JP2008542528A5 (he) | ||
JP2008513426A5 (he) | ||
JP2008517002A5 (he) | ||
JP2006506499A5 (he) | ||
JP2008513427A5 (he) | ||
JP2005524670A5 (he) | ||
JP2006511228A5 (he) | ||
JP2009509934A5 (he) | ||
IL186851A0 (en) | Styrylsulfonamides, their manufacture and use as pharmaceutical agents | |
DE602006018617D1 (de) | Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten | |
JP2006505577A5 (he) | ||
JP2007508806A5 (he) | ||
JP2005531640A5 (he) | ||
RU2003110288A (ru) | Вещество, обладающее антидепрессивной активностью |